Our innovative solution brings affordable, high-quality diagnostics to everyone, everywhere.
Learn More
Collaborate with us to deploy innovative diagnostic solutions, ensuring better health outcomes for communities.
Learn More
Speed up your test development process and enhance test performance by licensing our innovative diagnostic technology.
Learn MoreUbique Biotech pioneers precision diagnostics with AI-driven synthetic reagents, ensuring unparalleled specificity for accurate disease detection worldwide. These reagents are seamlessly integrated into various diagnostic formats, including ELISA and rapid point-of-care tests, advancing healthcare with each breakthrough.
When it comes to large-scale screening, antigen and antibody testing shine for their affordability, scalability, and minimal lab requirements compared to molecular diagnostics. Antigen and antibody tests provide rapid results at lower costs, making them ideal for quickly assessing the prevalence of diseases in communities without extensive laboratory setups.
Precision diagnostics with AI-driven synthetic reagents, ensuring unparalleled specificity for accurate disease detection worldwide.
Scalable diagnostic solutions, making precise healthcare accessible to all, regardless of location or resources.
Ethical and sustainable practices, from eliminating animal use to reducing environmental impact, ensuring a healthier future for all.
We are a biotech startup founded in 2022 with a bold vision for the future of healthcare. From our inception, we've been driven by a singular mission: to revolutionize diagnostics and make them accessible to all.
Our team combines expertise, passion, and innovation to develop cutting-edge solutions that prioritize accuracy, affordability, and accessibility. From antigen and antibody diagnostics, we're at the forefront of the latest advancements in biotechnology.
USA, New York: HQ
Mexico, Morelos: Lab
Argentina: Buenos Aires: R&D